Pending research issues in male condom use promotion

Sexual Health

Volumn 5, Issue 4, 2008, Pages 317-319

  Crosby, Richard ^a,b   Warner, Lee ^c  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b INDIANA UNIVERSITY   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Condom effectiveness; Condom failure; Sexual behaviour; Sexually transmissible infections

Indexed keywords

WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONDOM; DIAGNOSTIC TEST; HEALTH PROGRAM; HEALTH PROMOTION; HERPES SIMPLEX VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MEDICAL ETHICS; MEDICAL RESEARCH; REVIEW; SCREENING TEST; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS INFECTION;

CONDOMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MALE; MASS MEDIA; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 56649122017     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH08080     Document Type: Review

References (30)

1. National Institute of Allergies and Infectious Disease. Workshop Summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Bethesda, MD: National Institute of Allergies and Infectious Disease; 2001.
2. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82: 454-61.
3. Warner L, Stone KM, Macaluso M, Buehler J, Austin HD. Condom use and risk of gonorrhea and chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis 2006; 33: 36-51. doi: 10.1097/01.olq.0000187908.42622.fd
4. Weller S, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2001; (1), CD003255.
5. Warner L, Macaluso M, Austin HD, Kleinbaum DK, Artz L, Fleenor ME, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161: 765-73. doi: 10.1093/aje/kwi094
6. Warner L, Newman DR, Austin HD, Kamb ML, Douglas JM Jr, Malotte CK, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004; 159: 242-51. doi: 10.1093/aje/kwh044
7. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354: 2645-54. doi: 10.1056/NEJMoa053284
8. Hogewoning CJA, Bleeker MCG, van den Brule AJC, Voorhorst FJ, Snijders PJF, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized controlled trial. Int J Cancer 2003; 107: 811-16. doi: 10.1002/ijc.11474
9. Crosby RA, Salazar LF, DiClemente RJ, Yarber WL, Caliendo AM, Staples-Horne M. Accounting for failures may improve precision: evidence supporting improved validity of self-reported condom use. Sex Transm Dis 2005; 32: 513-15. doi: 10.1097/01.olq.0000170442.10150.28
10. Crosby RA, Sanders S, Yarber WL, Graham C, Dodge B. Condom use errors and problems among college men. Sex Transm Dis 2002; 29: 552-7. doi: 10.1097/00007435-200209000-00010
11. Crosby RA, Sanders SA, Yarber WL, Graham CA. Condom use errors and problems: a neglected aspect of studies assessing condom effectiveness. Am J Prev Med 2003; 24: 367-70. doi: 10.1016/S0749-3797(03)00015-1
12. Civic D, Scholes D, Ichikawa L, Grothaus L, McBride CM, Yarnall KSH. Ineffective use of condoms among young women in managed care. AIDS Care 2002; 14: 779-88. doi: 10.1080/0954012021000031859
13. Macaluso M, Kelaghan J, Artz L, Austin H, Fleenor M, Hook EW, et al. Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis 1999; 26: 450-7. doi: 10.1097/00007435-199909000- 00006
14. Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices: implications for evaluating method and user effectiveness. Sex Transm Dis 1998; 6: 273-7.
15. Shlay JC, McClung MW, Patnaik JL, Douglas JM. Comparison of sexually transmitted disease prevalence by reported condom use: errors among consistent condom users seen at an urban sexually transmitted disease clinic. Sex Transm Dis 2004; 31: 526-32. doi: 10.1097/01.olq.0000137897.17919.d1
16. Macaluso M, Blackwell R, Jamieson DJ, Kulczycki A, Chen MP, Akers R, et al. Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol 2007; 166: 88-96. doi: 10.1093/aje/kwm046
17. Koutsky L, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645-51. doi: 10.1056/NEJMoa020586
18. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27. doi: 10.1056/NEJMoa021641
19. van de Wijgert J, Coggins C. Microbicides to prevent heterosexual transmission of HIV: ten years down the road. AIDScience 2002; 15: 23-8.
20. Mantell JE, Myer L, Carballo-Dieguez A, Steina Z, Ramjee G, Morar NS, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med 2005; 60: 319-30. doi: 10.1016/j.socscimed.2004. 05.011
21. Ramjee G, Shattock R, Delany S, McGowan I, Morar N, Gottemoeller M. Microbicides 2006 conference. AIDS Res Ther 2006; 3: 25. doi: 10.1186/1742-6405-3-25
22. Kajubi P, Kamya MR, Kamya S, Chen S, McFarland W, Hearst N. Increasing condom use without reducing HIV risk: results of a controlled community trial in Uganda. J Acquir Immune Defic Syndr 2005; 40: 77-82. doi: 10.1097/01.qai.0000157391.63127.b2
23. Smoak ND, Scott-Sheldon LA, Johnson BT, Carey MP. Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants. J Acquir Immune Defic Syndr 2006; 41: 374-84. doi: 10.1097/01.qai.0000185575.36591.fc
24. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1-60. RR-6
25. Crosby RA, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytic considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect 2002; 78: 228-31. doi: 10.1136/sti.78.4.228
26. Crosby RA, Graham CA, Yarber WL, Sanders SA. If the condom fits, wear it: a qualitative study of young African American men. Sex Transm Infect 2004; 80: 306-9. doi: 10.1136/sti.2003.008227
27. Crosby RA, Yarber WL, Sanders SA, Graham CA. Condom discomfort and associated problems with their use among university students. J Am College Health 2005; 54: 143-8. doi: 10.3200/JACH.54.3.143-148
28. Crosby RA, Yarber WL, Sanders SA, Graham CA, McBride K, Milhausen RR, et al. Men with broken condoms: who and why? Sex Transm Infect 2007; 83: 71-5. doi: 10.1136/sti.2006.021154
29. Cook L, Nanda K, Taylor D. Randomized crossover trial comparing the eZ.on plastic condom and a latex condom. Contraception 2001; 63: 25-31. doi: 10.1016/S0010-7824(00)00193-1
30. Trussell J, Warner DL, Hatcher RA. Condom breakage and slippage rates. Fam Plann Perspect 1992; 24: 20-3. doi: 10.2307/2135721